Liver Metastases
Liver metastases occur when cancer cells from another part of the body, such as the colon or rectum, spread to the liver. This can lead to various symptoms and complications as the liver is affected by the cancer.
Colorectal Liver Metastases: SGM-101 and Indocyanine Green Imaging
We are studying the use of two imaging agents during surgery for colorectal liver metastases to see if they help surgeons remove cancerous tissue more effectively. This trial aims to improve surgical accuracy and patient outcomes.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have liver metastases from colorectal cancer?
- Are you currently pregnant or breastfeeding?
- Have you ever had an anaphylactic shock?
- Do you have a serious infection like HIV, hepatitis B, or hepatitis C?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Sgm-101
Chimeric Monoclonal Antibody Against Carcinoembryonic Antigen
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Leiden University Medical Center
Surgery
Leiden, Netherlands
Sponsor: Leiden University Medical Center
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.